Results 111 to 120 of about 69,700 (263)

PAI-1 [PDF]

, 2019
openaire   +1 more source

Corrosion Inhibition of S275 Carbon Steel in CO2 Capture Systems Using Monoethanolamine (MEA) Solvent

Materials and Corrosion, EarlyView.
Corrosion inhibitors CuSO4 and NaVO3 achieved up to 98% inhibition efficiency for carbon steel S275 in CO2‐loaded MEA solvent, reducing corrosion rates to 9.4 µm/year—outperforming costly stainless steel SS 316 L at a fraction of the cost. ABSTRACT Corrosion in CO2 capture units significantly impacts safety and costs.
Eleni Lamprou, Fani Stergioudi, Georgios Skordaris, Nikolaos Michailidis, Evie Nessi, Athanasios I. Papadopoulos, Panagiotis Seferlis   +6 more
wiley   +1 more source

Artificial Voices, Real Causes: The Dilemma of Virtual Influencer‐Driven Brand Activism

Psychology &Marketing, EarlyView.
ABSTRACT Brands are more frequently adopting virtual influencers (VIs) to lead activism campaigns. However, little is known about when and how such activism effectively drives consumer engagement. This research, in Study 1, examines 14,464 Instagram posts from 18 diverse VIs using large‐scale analytics to assess engagement intensity and the dynamics of
Sampa Anupurba Pahi, Debasis Pradhan, Abhisek Kuanr, Baidyanath Biswas, Jingyu Zhu   +4 more
wiley   +1 more source

Measurement of total PAI-1 and interpretation of results—especially for low PAI-1 values

Japanese Journal of Thrombosis and Hemostasis, 2023
Takayuki IWAKI, Kazuo UMEMURA, Yuko SUZUKI, Tetsumei URANO   +3 more
openaire   +1 more source

Phenotypic Exploration in Patients with Heterozygous Variant in AFG3L2 Gene: A Case‐Series and Literature Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Variants in AFG3‐Like Matrix AAA Peptidase, Subunit 2 (AFG3L2) gene are associated with diverse clinical phenotypes. Here, we describe phenotypic findings of two unrelated children with de novo heterozygous variant and one family with inherited heterozygous variant in AFG3L2 gene.
Sangeetha Yoganathan, Laura Tochen, Jacky Ganguly, Sayoni Roy Chowdhury, Haya S AlFaris, Vivek Pai, Andrea LeBlanc‐Millar, Sara Breitbart, Hrishikesh Kumar, Manohar Shroff, Arun Reginald, Grace Yoon, Alfonso Fasano, George M Ibrahim, Carolina Gorodetsky   +14 more
wiley   +1 more source

PAI-1 Inhibition in experimental venous thrombosis. [PDF]

Phlebology
Shaydakov ME, Emal CD, Rainey JP, Lawrence DA, Diaz JA.   +4 more
europepmc   +1 more source

PAI-1 in diabetic nephropathy [PDF]

Kidney International, 2005
Hertig, Alexandre, Pelle, Gaelle, Rondeau, Eric   +2 more
openaire   +1 more source

Characteristics, properties and limitations of per‐ or polyfluoroalkyl substances (PFASs) and fluoropolymers

Polymer International, EarlyView.
An overview and categorization of man‐made per‐ or polyfluoroalkyl substances (PFASs) including low‐molar‐mass and high‐molar‐mass fluorochemicals, and their international regulations is presented. Though certain PFASs are toxic, bioaccumulative and cross the human cellular membranes, others, such as fluoropolymers, are safe, reliable and involved in ...
Bruno Améduri
wiley   +1 more source

The expanding landscape of adipokines: emerging roles of PAI-1 and vaspin in cardiometabolic diseases. [PDF]

Front Endocrinol (Lausanne)
Kocabas S, Sanlier N.
europepmc   +1 more source

Silencing of PAI-1 using siRNA-lipid nanoparticles reduces thrombosis and prolongs life span in murine models. [PDF]

Blood
Ferraresso F, Skaer CW, Wei Z, Hur WS, Yu H, Seadler M, Chen THY, Dai W, Paul M, Lapointe C, Ketelboeter LM, Lund H, Rodriguez GG, Juang LJ, Strilchuk AW, Zhang Y, Cullis PR, Dyer MR, Gerras AL, Shi Q, Luyendyk JP, Flick MJ, Zheng Z, Kastrup CJ.   +23 more
europepmc   +1 more source